Takeda Pharmaceutical Co. Ltd. is looking to sell its Osaka, Japan-based headquarters ahead of its £46 billion acquisition of Shire PLC, Nikkei Asian Review reported.
The Japanese pharmaceutical company hopes to find a buyer this year through a bidding process and estimates the headquarters and surrounding buildings to fetch about ¥60 billion.
Takeda plans to focus its resources on the pharmaceutical business by selling off certain assets not related to pharmaceuticals. Selling off noncore properties will also help the company lessen the impact of interest-bearing debt related to Shire deal, according to the report.
Takeda recently opened new global headquarters in Tokyo which will serve as its head office for its operations worldwide.
As of July 4, US$1 was equivalent to ¥110.54.